RhumbLine Advisers
STIM icon

RhumbLine Advisers’s Neuronetics STIM Stock Holding History

RhumbLine Advisers’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-41,843
Closed -$60.7K – 4244
2026
Q1 		$60.7K Sell
41,843
-6,564
-14% -$10.4K ﹤0.01% 3556
2025
Q4 		$66.8K Sell
48,407
-7,188
-13% -$15K ﹤0.01% 3583
2025
Q3 		$152K Buy
55,595
+3,119
+6% +$11.1K ﹤0.01% 3358
2025
Q2 		$183K Buy
+52,476
New +$207K ﹤0.01% 3268
2022
Q2 		– Sell
-19,248
Closed -$58K – 3228
2022
Q1 		$58K Buy
19,248
+559
+3% +$1.89K ﹤0.01% 2964
2021
Q4 		$83K Sell
18,689
-593
-3% -$2.9K ﹤0.01% 2955
2021
Q3 		$126K Buy
19,282
+1,479
+8% +$14.2K ﹤0.01% 2972
2021
Q2 		$285K Buy
+17,803
New +$246K ﹤0.01% 2812
2020
Q2 		– Sell
-16,160
Closed -$31K – 3111
2020
Q1 		$31K Hold
16,160
– – ﹤0.01% 2889
2019
Q4 		$73K Buy
16,160
+73
+0.5% +$454 ﹤0.01% 2897
2019
Q3 		$134K Sell
16,087
-125
-0.8% -$1.37K ﹤0.01% 2841
2019
Q2 		$203K Buy
16,212
+2,811
+21% +$39.7K ﹤0.01% 2788
2019
Q1 		$204K Buy
+13,401
New +$222K ﹤0.01% 2745

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RhumbLine Advisers's STIM Position: Q2 2026 in Review

RhumbLine Advisers sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 41,843 shares — an estimated $60.7K sold.

RhumbLine Advisers first reported a position in STIM in Q1 2019 and held it in 13 quarters. The position peaked at $285K in Q2 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • RhumbLine Advisers reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • RhumbLine Advisers sold 41,843 Neuronetics shares in Q2 2026, an estimated $60.7K.
  • RhumbLine Advisers first reported a position in Neuronetics in Q1 2019 and held it in 13 quarters.
  • RhumbLine Advisers's Neuronetics position peaked at $285K in Q2 2021.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.